Cargando…

Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

BACKGROUND: With the application of immune checkpoint inhibitors (ICIs) in cancer treatment, more and more attention has been paid to checkpoint inhibitor-related pneumonitis (CIP), which requires a better understanding of its clinical characteristics and therapeutic effects. METHODS: The clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Li, Xie, Mei, Ma, Xidong, Huang, Aiben, Song, Jialin, Yao, Jie, Deng, Hui, Zhang, Duchao, Zang, Xuelei, Ren, Fangping, Gao, Jie, Wu, Chongchong, Wang, Yuanyong, Zhang, Xin, Bao, Xinyu, Pan, Lei, Xue, Xinying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983156/ https://www.ncbi.nlm.nih.gov/pubmed/36869304 http://dx.doi.org/10.1186/s12885-023-10649-0

Ejemplares similares

Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis
por: Huang, Aiben, et al.
Publicado: (2021)

Tertiary lymphoid structures in lung adenocarcinoma: characteristics and related factors
por: Ren, Fangping, et al.
Publicado: (2022)

Computed tomography (CT) characteristics and pathologic basis of ciliated muconodular papillary tumors of the lung
por: Xue, Xinying, et al.
Publicado: (2023)

Consolidation radiographic morphology can be an indicator of the pathological basis and prognosis of partially solid nodules
por: Xie, Mei, et al.
Publicado: (2022)

PIWI-interacting RNAs in cancer: Biogenesis, function, and clinical significance
por: Yao, Jie, et al.
Publicado: (2022)

Comparison of clinical features of pulmonary cryptococcosis with and without central nervous system involvement in China
por: Xue, Xinying, et al.
Publicado: (2021)

The prognosis of different types of pleural tags based on radiologic-pathologic comparison
por: Meng, Yao, et al.
Publicado: (2022)

Comparative study of imaging and pathological evaluation of pneumonic mucinous adenocarcinoma
por: Han, Jun, et al.
Publicado: (2021)

Cryptococcosis caused by cryptococcus gattii: 2 case reports and literature review
por: Xue, Xinying, et al.
Publicado: (2020)

Gene, virulence and related regulatory mechanisms in Cryptococcus gattii : Gene, virulence and regulatory mechanisms in C. gattii
por: Huang, Yemei, et al.
Publicado: (2022)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022)

Comparative study of primary pulmonary cryptococcosis with multiple nodules or masses by CT and pathology
por: Wang, Dongxu, et al.
Publicado: (2018)

Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis
por: Lin, Xinqing, et al.
Publicado: (2022)

Chronic immune checkpoint inhibitor pneumonitis
por: Naidoo, Jarushka, et al.
Publicado: (2020)

Correction: Chronic immune checkpoint inhibitor pneumonitis
Publicado: (2020)

Advances in CT features and radiomics of checkpoint inhibitor-related pneumonitis: A short review
por: Huang, Jie, et al.
Publicado: (2023)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
por: Wang, Hanping, et al.
Publicado: (2019)

Combating increased antifungal drug resistance in Cryptococcus, what should we do in the future? : Antifungal drug resistance in Cryptococcus
por: Deng, Hengyu, et al.
Publicado: (2023)

Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis
por: Li, Yanlin, et al.
Publicado: (2022)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Risk factors and immunomodulators use in steroid-refractory checkpoint inhibitor pneumonitis
por: Li, Yanlin, et al.
Publicado: (2023)

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
por: Wang, Wenxian, et al.
Publicado: (2022)

Treatment of steroid‐resistant checkpoint inhibitor pneumonitis with pirfenidone: A case report
por: Miao, Kang, et al.
Publicado: (2021)

Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer
por: Chao, Yencheng, et al.
Publicado: (2022)

Characterization of immunomodulatory factors and cells in bronchoalveolar lavage fluid for immune checkpoint inhibitor-related pneumonitis
por: Wang, Peng-Mei, et al.
Publicado: (2023)

Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation
por: Zhu, Shicong, et al.
Publicado: (2020)

Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor–related pneumonitis
por: Zhou, Chengzhi, et al.
Publicado: (2022)

Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis
por: Chen, Xinru, et al.
Publicado: (2020)

Catalog of Lung Cancer Gene Mutations Among Chinese Patients
por: Xue, Xinying, et al.
Publicado: (2020)

Integrative analysis of multi‐omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer
por: Chen, Yabin, et al.
Publicado: (2021)

HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
por: Correale, Pierpaolo, et al.
Publicado: (2020)

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy
por: Serzan, Michael T, et al.
Publicado: (2020)

Long-term outcomes in patients with immune checkpoint inhibitor induced pneumonitis
por: Davis Puente, Andrea, et al.
Publicado: (2023)

Identification and prediction of immune checkpoint inhibitors-related pneumonitis by machine learning
por: Gong, Li, et al.
Publicado: (2023)

Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis
por: Cui, Pengfei, et al.
Publicado: (2023)

Anti-PD-1/PD-L1 and anti-CTLA-4 associated checkpoint inhibitor pneumonitis in non-small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
por: Hu, Xiao, et al.
Publicado: (2023)

Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review
por: Hao, Yuxuan, et al.
Publicado: (2022)

Dosimetric Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
por: Bi, Jianping, et al.
Publicado: (2022)

Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network
por: Wang, Yuanyong, et al.
Publicado: (2020)

Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report
por: Deng, Jiaxi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dto0a2hes2p539j0hsh9cuhrh1